Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Metairie, Louisiana 25 trials found
New Search
Filter
Trial Phase
Study Type
Galleri® in the Medicare Population.
NAINTERVENTIONAL Fort Smith, Arkansas +4 more
RECRUITING
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
PHASE3INTERVENTIONAL Fort Smith, Arkansas +4 more
RECRUITING
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver)
NAINTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
PHASE1INTERVENTIONAL Santa Monica, California +4 more
RECRUITING
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
PHASE1, PHASE2INTERVENTIONAL Fountain Valley, California +4 more
RECRUITING
Pancreatic Cancer Detection Consortium
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
N/AOBSERVATIONAL Phoenix, Arizona +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
PHASE3INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source
PHASE1, PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NAINTERVENTIONAL Goodyear, Arizona +4 more
RECRUITING
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
PHASE2INTERVENTIONAL Kingman, Arizona +4 more
RECRUITING
Collection of Samples USOPTIVAL Study
N/AOBSERVATIONAL Chula Vista, California +4 more
RECRUITING
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type